首页> 外文期刊>Therapeutic delivery >Interview: Interview with Nejat Düzgüne?: Liposomal carriers for gene delivery
【24h】

Interview: Interview with Nejat Düzgüne?: Liposomal carriers for gene delivery

机译:访谈:NejatDüzgüne访谈?:用于基因传递的脂质体载体

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Signet ring cell carcinoma (SRC) of the stomach is a histological type based on microscopic characteristics. Although the distinctive clinicopathological features of SRC have been reported, results are inconsistent and survival outcomes are uncertain. Methods: We retrospectively studied 769 patients with gastric carcinoma who underwent gastrectomy in our institute from 1999 to 2009. Among them, 326 patients (42.4 %) had early gastric cancer (EGC) and 443 patients (57.6 %) had advanced gastric cancer (AGC). Sex, age, tumor location, macroscopic type, tumor size, microscopic invasion, and survival rate were compared between patients with SRC, differentiated-, and undifferentiated-type gastric carcinomas. Results: Fifty-one patients (15.6 %) had SRC in EGC; there were significant differences in sex, age, location, macroscopic type, and size between SRC and the differentiated histological type. However, there was no difference between SRC and undifferentiated-type gastric carcinoma, except for the macroscopic type. Fifty-seven patients (12.9 %) had SRC in AGC. Sex, age, location, size, macroscopic type, perineural invasion, N stage, and hepatic metastasis were significantly different between SRC and the differentiated histological type. Undifferentiated-type gastric carcinoma differed in sex, macroscopic type, and hepatic metastasis. The overall survival rate differed between SRC and other cell types (P < 0.001). Among all the study patients, age [hazard ratio (HR) 1.013, P = 0.041] and tumor, node, and metastasis (TNM) stage (HR 2.350, P < 0.001) were important factors for predicting survival. Omitting patients with palliative resection or metastases, TNM stage was still an important factor for survival (HR 2.077, P < 0.001). Conclusions: Patients with SRC showed similar clinicopathological features with undifferentiated histology. The survival of patients with SRC reflected a better prognosis in patients with undifferentiated gastric carcinoma. However, when narrowing the patients to those with EGC only, survival in EGC patients exhibited no difference between histological types. Among AGC patients, SRC patients had a worse prognosis than other cell types.
机译:背景:胃的印戒细胞癌(SRC)是一种基于微观特征的组织学类型。尽管已经报道了SRC的独特临床病理特征,但结果不一致且生存结果不确定。方法:回顾性分析我院1999年至2009年行胃切除术的769例胃癌患者,其中早期胃癌(EGC)326例(42.4%),晚期胃癌(AGC)443例(57.6%)。 )。比较了SRC,分化型和未分化型胃癌患者的性别,年龄,肿瘤位置,宏观类型,肿瘤大小,显微浸润和生存率。结果:51名患者(15.6%)在EGC中出现SRC; SRC和分化的组织学类型之间在性别,年龄,位置,宏观类型和大小方面存在显着差异。但是,SRC和未分化型胃癌之间没有区别,除了肉眼可见的类型。五十七名患者(12.9%)在AGC中患有SRC。 SRC和分化的组织学类型之间的性别,年龄,位置,大小,宏观类型,神经周浸润,N期和肝转移显着不同。未分化型胃癌在性别,宏观类型和肝转移方面有所不同。 SRC和其他细胞类型之间的总生存率有所不同(P <0.001)。在所有研究患者中,年龄[危险比(HR)1.013,P = 0.041]和肿瘤,淋巴结转移(TNM)阶段(HR 2.350,P <0.001)是预测存活率的重要因素。省略姑息性切除或转移的患者,TNM分期仍是生存的重要因素(HR 2.077,P <0.001)。结论:SRC患者表现出相似的临床病理特征,组织学未分化。 SRC患者的生存率反映了未分化胃癌患者的预后更好。但是,当将患者缩小为仅患有EGC的患者时,EGC患者的生存率在组织学类型之间没有差异。在AGC患者中,SRC患者的预后比其他细胞类型差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号